Aggressive Systemic Mastocytosis Resulting in Hepatic Fibrosis and Non-Cirrhotic Portal Hypertension

Aggressive systemic mastocytosis [ASM] is a rare hematologic disorder characterized by mast cell infiltration of extracutaneous organs. Hepatic involvement is uncommon and rarely progresses to fibrosis or portal hypertension. We present a 60-year-old male with abdominal distension, hepatosplenomegaly, and thrombocytopenia, ultimately diagnosed with ASM after bone marrow and liver biopsies confirmed mast cell infiltration. Despite treatment with avapritinib, he developed noncirrhotic portal hypertension and expired due to multisystem complications. This case highlights the need to consider ASM in patients with cryptogenic liver disease and underscores the importance of early diagnosis and multidisciplinary management in improving outcomes.

Authors

Institutions

Publication Details

Journal
Livers
Published
2026-08-28
DOI
https://doi.org/10.3390/livers6050084
Primary Topic
Mast cells and histamine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aggressive Systemic Mastocytosis Resulting in Hepatic Fibrosis and Non-Cirrhotic Portal Hypertension

Nimish Thakral, Bipneet Singh, Katharine Hunter Cook
Livers
Mast cells and histamine
article

Aggressive Systemic Mastocytosis Resulting in Hepatic Fibrosis and Non-Cirrhotic Portal Hypertension

Nimish Thakral, Bipneet Singh, Katharine Hunter Cook
article en

Abstract

Aggressive systemic mastocytosis [ASM] is a rare hematologic disorder characterized by mast cell infiltration of extracutaneous organs. Hepatic involvement is uncommon and rarely progresses to fibrosis or portal hypertension. We present a 60-year-old male with abdominal distension, hepatosplenomegaly, and thrombocytopenia, ultimately diagnosed with ASM after bone marrow and liver biopsies confirmed mast cell infiltration. Despite treatment with avapritinib, he developed noncirrhotic portal hypertension and expired due to multisystem complications. This case highlights the need to consider ASM in patients with cryptogenic liver disease and underscores the importance of early diagnosis and multidisciplinary management in improving outcomes.

LiversVol. 6(5)
University of Kentucky (US)
Good health and well-being
Openalex Percentile: Top 16%
Mast cells and histamine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Aggressive Systemic Mastocytosis Resulting in Hepatic Fibrosis and Non-Cirrhotic Portal Hypertension — Nimish Thakral, Bipneet Singh, et al. · Livers (2026) | TGRS Research Map | TGRS